Matthew M. Walsh - Feb 28, 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role: Chief Financial Officer
Signature: /s/ Faye C. Brown, as Attorney-in-Fact for Matthew M. Walsh
Stock symbol: OGN
Transactions as of: Feb 28, 2024
Transactions value $: -$205,530
Form type: 4
Date filed: 3/1/2024, 04:24 PM
Previous filing: Aug 8, 2023
Next filing: Apr 2, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGN	Common Stock	Options Exercise		+33K	+63.05%		85.5K	Feb 28, 2024	Direct	F1
transaction	OGN	Common Stock	Tax liability	-$206K	-11.4K	-13.33%	$18.04	74.1K	Feb 28, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGN	Restricted Stock Units	Options Exercise	$0	-33K	-100%	$0.00^*	0	Feb 28, 2024	Common Stock	33K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit converts into one share of Organon & Co. common stock.
F2	As previously reported, these Restricted Stock Units vested on December 31, 2023, and shares of Organon & Co. common stock were distributed to the Reporting Person on February 28, 2024.